Fine Needle Biopsy of Solid Pancreatic Mass Lesions

Status unconfirmed · Not applicable

Conditions studied: Pancreatic Neoplasms

In brief

This is a randomized trial to evaluate and directly compare the tissue quality, diagnostic sucess and safety profile of four different Fine Needle Biopsy needles.

Key facts

Study ID

NCT04085055

Run by

AdventHealth

People needed

130

Starts

2019-09-09

Expected to finish

2020-12-01

Last updated by the study team

2020-08-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All patients referred for EUS-guided tissue acquisition of suspected or confirmed solid pancreatic mass lesions visualized on any radiological imaging
• Able and willing to provide written or verbal consent
• ≥ 18 years old
• Able to undergo conscious sedation for EUS procedure

You may not qualify if…

• <18 years old
• Unable to obtain informed consent from the patient
• Medically unfit for sedation
• Pregnant patients
• No pancreatic mass lesions visualized on EUS
• Irreversible coagulopathy as determined by platelet count < 50,000/microL or International Normalized Ratio (INR) > 1.5
• Unable to stop anti-platelet agents prior to the procedure

Where it is running

• AdventHealth Orlando — Orlando, Florida, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.